Is Zydus Wellness overvalued or undervalued?

Sep 26 2025 08:02 AM IST
share
Share Via
As of September 25, 2025, Zydus Wellness is fairly valued with a PE ratio of 46.80, lower than its peers Hindustan Unilever and Nestle India, and has outperformed the Sensex with a year-to-date return of 21.89%.
As of 25 September 2025, the valuation grade for Zydus Wellness has moved from expensive to fair. The company is currently fairly valued based on its financial metrics. Key ratios include a PE Ratio of 46.80, an EV to EBITDA of 39.85, and a ROCE of 6.11%.

In comparison to its peers, Zydus Wellness stands out with a lower PE ratio than Hindustan Unilever, which is at 56.06, and Nestle India, which has a PE of 75.21. This suggests that while Zydus Wellness is fairly valued, its peers are significantly more expensive. Notably, Zydus Wellness has outperformed the Sensex in the year-to-date return, with a gain of 21.89% compared to the Sensex's 3.87%, reinforcing its valuation story.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News